Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis Press Release
Dianthus Therapeutics Ph. 2 MaGic Data Investor Webcast Sep 8, 2025 8:00 AM EDT Webcast Supporting Materials Claseprubart Phase 2 MaGic Data Presentation 1.6 MB
